CYP2C18 Antibodies

Santa Cruz Biotechnology provides a broad selection of CYP2C18 monoclonal antibodies for research focused on understanding this important enzyme. CYP2C18 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CYP2C18 is a member of the cytochrome P450 superfamily, which plays a crucial role in the metabolism of various endogenous and exogenous compounds. CYP2C18 actively participates in the oxidative metabolism of drugs and holds significant importance in pharmacogenomics, as variations in expression can affect drug efficacy and toxicity. Understanding CYP2C18 function is essential for advancing personalized medicine and improving therapeutic outcomes. Researchers worldwide utilize CYP2C18 monoclonal antibodies to investigate drug metabolism pathways and their impact on patient care. Current studies with CYP2C18 monoclonal antibodies continue to reveal new insights about metabolic processes and drug interactions. Santa Cruz Biotechnology's high-quality CYP2C18 monoclonal antibodies enable researchers to make meaningful contributions to drug metabolism research and advance the field of personalized medicine.